Trial Radar AI
Clinical Trial NCT07456436 for Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials 50

Recruiting
Clinical Trial NCT07456436 is an observational study for Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm that is recruiting. It started on November 26, 2024 with plans to enroll 50 participants. Led by University of Southern California, it is expected to complete by November 26, 2027. The latest data from ClinicalTrials.gov was last updated on March 13, 2026.
Brief Summary
This study assesses patient awareness and understanding of cancer clinical trials.
Detailed Description
PRIMARY OBJECTIVE:

I. To develop a multi-level data-driven intervention to improve cancer patient engagement with cancer clinical trials.

OUTLINE: This is an observational study.

Patients review educational materials and complete surveys on study.

Official Title

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

Conditions
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Other Study IDs
NCT ID Number
NCT07456436
Start Date (Actual)
2024-11-26
Last Update Posted
2026-03-13
Completion Date (Estimated)
2027-11-26
Enrollment (Estimated)
50
Study Type
Observational
Status
Recruiting
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Observational
Patients review educational materials and complete surveys on study.
Non-Interventional Study
Non-interventional study
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Change in Baseline Survey Score
The survey is a validated instrument (CHEKS\*) evaluated patients' knowledge and beliefs about cancer clinical trials (CCTs) before and after exposure to educational stimuli (written and video) detailing the purpose and characteristics of CCTs. The survey scores knowledge and beliefs about CCTs on a 100-point scale.The survey is collected before and after education materials are provided. The change in survey score will be analyzed. A paired t-test will be used to examine changes in CCT knowledge and Chi-Square tests of association to determine whether CCT knowledge and beliefs are associated with sociodemographic variables. \*Chung A, Donley T, Hays RD, et al. Development and evaluation of the Clinical Trial HEalth Knowledge and Beliefs Scale (CHEKS). Int J Environ Res Public Health. 2022;19(14):8660. doi:10.3390/ijerph19148660
Through study completion, up to 1 year
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
21 Years
Eligible Sexes
All

  • Eligible patient participants will be:

    • Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported
    • Have been diagnosed any cancer type

  • Participants (patients) will be excluded if they:

    • Are unable to give informed consent
    • Are unable to speak English or Spanish
University of Southern California logoUniversity of Southern California224 active studies to explore
No contact data.
1 Study Locations in 1 Countries

California

USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States
Chanita Hughes-Halbert, Contact, 323-442-1192, [email protected]
Chanita Hughes-Halbert, Principal Investigator
Recruiting